BMP2 and cancer: Beachler et al[28] studied the use of C.BMP-2 and the risk of malignant tumors using the Surveillance, Epidemiology, and End Results-Medicare system from 2004 to 2011 and found no correlation between the use of C.BMP-2, incidence of malignant tumors, and the resultant mortality.